Show simple item record

Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]

dc.contributor.authorCastillo E.
dc.contributor.authorPrada-Arismendy J.
dc.date.accessioned2020-08-28T22:27:36Z
dc.date.available2020-08-28T22:27:36Z
dc.date.issued2019
dc.identifier.urihttp://hdl.handle.net/20.500.12622/3143
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85073739486&doi=10.15446%2frevfacmed.v67n3.68417&partnerID=40&md5=7c45a39e018fe8d40526746065db9a08
dc.titleBevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]spa
dc.title.alternativeRevista Facultad de Medicina
dc.typeinfo:eu-repo/semantics/article
dc.rights.accessrightsinfo:eu-repo/semantics/closedAccess
dc.relation.citationissue3spa
dc.identifier.doi10.15446/revfacmed.v67n3.68417
dc.relation.citationvolume67
dc.relation.citationstartpage343
dc.relation.citationendpage347
dc.type.versioninfo:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record